SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN CANCERS, INFLAMMATORY DISEASES AND INFECTIONS
申请人:GUNDLURU Mahesha K.
公开号:US20160229861A1
公开(公告)日:2016-08-11
The present invention relates to novel securinine and norsecurine analogs and their applicapility in treating cellular proliferative disorders.
SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN INHIBITING MYELOPEROXIDASE
申请人:GUNDLURU Mahesh K.
公开号:US20160250196A1
公开(公告)日:2016-09-01
The present invention relates to novel securinine and norsecurine analogs that have reduced or non-reduced gamma-delta bond. The present invention also provides for methods of using securinine analogs, comprising administering one or more of the analogs to a myeloperoxidase enzyme, such as an enzyme with or proximal to a cell. As set out herein, the securinine analogs directly bind to and inhibit myeloperoxidase (MPO) activity. Accordingly, contacting or administering the analogs to an MPO enzyme allows for inhibition of MPO activity.
US9827229B2
申请人:——
公开号:US9827229B2
公开(公告)日:2017-11-28
Synthesis and biological activity of amination products of the alkaloid securinine
作者:S. G. Klochkov、S. V. Afanas’eva、V. V. Grigor’ev
DOI:10.1007/s10600-008-9013-3
日期:2008.3
A method for stereospecific synthesis of allomargaritarin and other amination products of the natural alkaloidsecurinine was developed. Stereoselective nucleophilic addition of an amine at the double bond of the azobicyclooctane moiety of securinin was achieved by using ytterbium triflate as the catalyst. The biological activity of securining caused by adding pharmacophores to the molecule was shown